Clinical trial
Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy
NCT03030300 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy
- Lead sponsor
- Qianfoshan Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- February 28, 2015
- Enrollment
- 170 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
type2 diabetes